Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
2013 · Breast Cancer Research and Treatment · 248 citations
https://doi.org/10.1007/s10549-013-2711-y
A
Adri C. Voogd
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
458
Papers
12.4K
Citations
61
h-index
213
i10-index
Adri C. Voogd is an academic researcher from Maastricht University Medical Centre. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Global Cancer Incidence and Screening. The author has an h-index of 61, co-authored 390 publications.
ORCID: 0000-0002-8041-2720Papers by this author
worksClinical management of women with metastatic breast cancer: a descriptive study according to age group
2006 · BMC Cancer · 142 citations
https://doi.org/10.1186/1471-2407-6-179
Early and late morbidity associated with axillary levels I–III dissection in breast cancer
2002 · Journal of Surgical Oncology · 97 citations
https://doi.org/10.1002/jso.10061
The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis
2000 · Breast Cancer Research and Treatment · 85 citations
https://doi.org/10.1023/a:1006447825160
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women
2016 · JNCI Journal of the National Cancer Institute · 83 citations
https://doi.org/10.1093/jnci/djw329
Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
2015 · Annals of Surgical Oncology · 77 citations
https://doi.org/10.1245/s10434-015-4603-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat